The best weight loss medication for men includes semaglutide (Ozempic , Wegovy ), tirzepatide (Mounjaro , Zepbound ), and ...

NVO gains CHMP backing for a higher-dose Wegovy, paving the way for potential EU approval in 2026 as study data show stronger ...

Bariatric doctors who regularly prescribe GLP-1s share how long the worst Ozempic side effects last, and the best ways to ...

Scientists have discovered that semaglutide, the active ingredient in drugs like Ozempic and Wegovy, offers a new benefit for ...

Johnson & Johnson, which did not apply for the national priority voucher, was granted the ticket based on results from a ...

Today, Form Health, the national leader in science-based obesity and cardiometabolic care, announced access to new programs ...

At present, around 59 million adults worldwide have diabetes, about 64 million are diagnosed with heart failure, and ...

The survey showed that while most of the doctors didn’t have top-of-mind awareness of oral semaglutide’s upcoming FDA ...

Dec 15 (Reuters) - The U.S. Food and Drug Administration said on Monday it has granted a national priority voucher to Johnson ...

System CEOs driving policy use data and relationships to influence lawmakers and shape healthcare delivery at state and federal levels.

Learn about semaglutide’s effectiveness and clinical trial results and whether it could be right for you in your MASH treatment plan.

Novo’s New Deal May End Wegovy Shortages. It Could Reshape the Pharma Industry Along the Way. Catalent says it worked on more than half of the new drugs approved by the FDA over the past 10 years.